论文部分内容阅读
本刊讯历时4个月的“小儿肺热咳喘口服液体内外抗呼吸道病毒药效学试验研究”近日完成。研究结果表明,该药对甲型流感、副流感等病毒所致的细胞病变均有治疗作用。
Our period of 4 months “Pediatric Hyperactivity Kechuan oral liquid anti-respiratory viral pharmacodynamic test” recently completed. The results show that the drug has a therapeutic effect on the cytopathic effect caused by viruses such as influenza A and parainfluenza.